kelly - Rivervest

03 Nov IN THE NEWS / RiverVest’s Pascal Krotee Wins Life Science Catalyst Award

Posted at 12:44h in RiverVest News by kelly 0 Comments

November 2023RiverVest's Pascal Krotee Wins Life Science Catalyst Award /*! elementor - v3.17.0 - 01-11-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} Pascal Krotee, Ph.D. RiverVest Senior Associate San Diego, CA (November 1, 2023) – Biocom California today announced the winners of its Eighth Annual Life Science Catalyst Award. RiverVest...

08 Aug EXPERT INSIGHT: Mitochondrial Challenges: Innovations in Research and Patient-Centered Care

Posted at 19:18h in Expert Insights by kelly 0 Comments

RiverVest's latest Expert Insight explores the role of patient advocacy groups in therapeutic drug development for patients with rare diseases such as mitochondrial disease. ...

03 Aug CASE STUDY: GOOD THERAPEUTICS

Posted at 16:26h in Case Study by kelly 0 Comments

This is a case study of RiverVest portfolio company Good Therapeutics, which was acquired by Roche in 2022 for $250 million upfront plus potential milestone returns....

13 Jun EXPERT INSIGHT / The Orphan Drug Act of 1983 by Niall O’Donnell, Ph.D.

Posted at 18:23h in Expert Insights by kelly 0 Comments

In this article, Managing Director Niall O’Donnell, Ph.D. discusses the law that transformed orphan drug development and how one actor’s starring role in its passage spurred 40 years of prolific, life-saving innovation. ...

24 Apr CASE STUDY: Standard Bariatrics

Posted at 19:39h in Case Study by kelly 0 Comments

This is a case study of RiverVest's role in financing and guiding Cincinnati-based portfolio company Standard Bariatrics through acquisition by Teleflex, Inc....

03 Jan IN THE NEWS / RiverVest’s Tom Melzer Forecasts St. Louis VC, Start-up Growth for 2020

Posted at 00:00h in RiverVest News by kelly 0 Comments

JAN 2020RiverVest's Tom Melzer Forecasts St. Louis VC, Start-up Growth for 2020 /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (January 3, 2020) St. Louis Business JournalRead the Press ReleasePerhaps no part of the St. Louis economy surged in the past decade more...

03 Nov IN THE NEWS / RiverVest’s Pascal Krotee Wins Life Science Catalyst Award

08 Aug EXPERT INSIGHT: Mitochondrial Challenges: Innovations in Research and Patient-Centered Care

03 Aug CASE STUDY: GOOD THERAPEUTICS

13 Jun EXPERT INSIGHT / The Orphan Drug Act of 1983 by Niall O’Donnell, Ph.D.

24 Apr CASE STUDY: Standard Bariatrics

03 Jan IN THE NEWS / RiverVest’s Tom Melzer Forecasts St. Louis VC, Start-up Growth for 2020

St. Louis

San Diego

Cleveland